CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- 8-K Event Other events
- 4 Open-market sale CHIEF ACCOUNTING OFFICER sold 2,432 shares at an average $6.64 ($16,147)
- 4 Open-market sale CHIEF TECHNOLOGY OFFICER sold 6,311 shares at an average $6.62 ($41,804)
- 4 Open-market sale CHIEF PROD & SUPPLY CHAIN OFF sold 5,194 shares at an average $6.64 ($34,491)
- 4 Open-market sale CHIEF OPERATING OFFICER sold 6,660 shares at an average $6.63 ($44,127)
- 4 Planned sale Chief Financial Officer sold 7,623 shares at an average $6.62 ($50,489)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 21,314 shares at an average $6.62 ($141,199)
- 4 Grant or award Director acquired 9,500 shares (grant or award)
- 4 Grant or award Director acquired 7,380 shares (grant or award)
- 4 Grant or award Director acquired 3,032 shares (grant or award)
- 4 Grant or award Director acquired 9,500 shares (grant or award)
- 4 Grant or award Director acquired 3,032 shares (grant or award)
- 4 Grant or award Director acquired 9,500 shares (grant or award)
- 4 Grant or award Director acquired 9,500 shares (grant or award)
- 4 Grant or award Director acquired 3,726 shares (grant or award)
- 4 Grant or award Director acquired 38,000 shares (grant or award)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 4 of 33 · 660 filings